Clinical Trial Update: P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety [Phase 3]

View source ↗

Summary

Phase 3b short-term study of CTN in patients with ADHD and comorbid anxiety is ongoing but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Generalized Anxiety Disorder
• Social Anxiety Disorder

Drugs mentioned

• CTN

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: ADHD, Anxiety | Phase 3 | Status: ACTIVE_NOT_RECRUITING